We searched MEDLINE from Jan 1, 2005, to April 30, 2018, but did not exclude commonly referenced landmark articles published before 2005. Primary search terms included: “drug“, “antibiotics”, “drug-induced”, “penicillin”, “beta-lactam”, “sulfonamide”, “nevirapine”, “abacavir”, “antiretroviral”, “rifampin”, “rifamycin”, “vancomycin”, “fluoroquinolone”, “anesthesia”, “itch”, “erythema”, “pruritus”, “rhinitis”, “wheezing”, “urticaria”, “hive”, “angioedema”, “edema”, “swelling”, “anaphylaxis”,
ReviewAntibiotic allergy
Introduction
Antibiotics can result in adverse drug reactions (ADRs) and hypersensitivity reactions (HSRs) through a variety of mechanisms. Antibiotic allergies are frequently documented in the electronic health record, which results in changes to the care of future infectious diseases. Inaccurately determined allergies might result in the use of unnecessarily broad-spectrum or inferior antibiotics, posing a threat to patient safety and public health. Despite these threats, the histories associated with documented allergies are rarely reconciled, or acted on, by the health-care team. Ideally, patients at low risk for allergy would have their allergy evaluated without specialist intervention, and high-risk patients would be referred for allergy diagnostic testing and have potential reaction mechanism(s) implicated. Although some allergy investigations are validated diagnostic tests approved by governing bodies globally, many tests for immunologically mediated drug hypersensitivity remain under investigation.
In this Review, we provide a global perspective on antibiotic allergies, with a focus on updated classification, epidemiology, effect on public health, diagnosis, and management. We also advise on the crucial steps required to appropriately combat unverified penicillin allergy labels as an emergent threat for individuals and public health.
Section snippets
Classification, presentation, and mechanism
ADRs include any untoward medication effect experienced at normal therapeutic doses of the drug, and HSRs are ADRs that are immunologically mediated. As our mechanistic understanding of ADRs improves, limitations of previous ADR classifications have become apparent. Consequently, a high-level classification of on-target and off-target reactions, with further categorisation of off-target immune and non-immune reactions has been proposed (figure 1).2, 3 Both on-target and off-target effects can
Adverse drug reactions and hypersensitivity reactions
ADRs account for more than 3% of hospital admissions16 and complicate the inpatient care of 10–20% of hospitalised patients.17, 18 Drug HSRs comprise up to 20% of ADRs and are reported in approximately 8% of general populations.19, 20 Cutaneous reactions, including rash and hives, are the most commonly reported HSRs.21, 22 Although most patients are labelled with an antibiotic allergy at the time of hospital admission, new onset cutaneous HSRs were found to affect approximately 2% of inpatients.
Unverified antibiotic allergy labels
Most patients labelled with a β-lactam allergy are not allergic (ie, they tolerate penicillin and related drugs).57 This mislabel occurs for a variety of reasons. First, the original reaction might not have been an allergy (there could be intolerance, a viral exanthem, or a drug-infection interaction). Even if the original reaction were immunological, it might not recur with re-challenge. IgE-mediated reactions to β-lactams can wane over time; approximately 80% of patients who are positive for
Effect of antibiotic allergy labels
Precise assessment and subsequent documentation of antibiotic allergies is a key mechanism to ensure patients do not receive a medication to which they are allergic. However, most allergy labels are untrue and less than 1% of reported antibiotic allergies globally are interrogated through allergy evaluation methods, despite known negative consequences of allergy mislabels for patients, health-care systems, and communities.
Diagnosis and management of suspected hypersensitivity
The evaluation of patients with antibiotic allergies begins with an allergy history that includes symptom details, timing of reaction, timing since reaction, treatment of the reaction, and relevant ingestions concurrent with, and since, the reaction. When relevant, review of historical details, such as: rash description, photos, and biopsy; concomitant medication list; concomitant diagnoses; laboratory; and imaging details should be obtained. Although allergy specialists widely agree on these
A global call for action
Although penicillin allergy evaluations are recognised as important by a variety of government bodies, foundations, and professional organisations,91, 120, 121, 122 there is no standard approach to penicillin allergy evaluation or documentation. However, a systematic approach to remove the penicillin allergy label is now warranted.
Global implementation of penicillin allergy evaluations must be supported on an international scale to improve the quality and safety of health care delivered to
Conclusions
Although antibiotic ADRs are commonly reported, immunologically mediated hypersensitivity is uncommon and true IgE-mediated antibiotic allergy is verified in only a small minority. For those with true antibiotic HSRs, appropriate specialty assessment is indicated to prevent future ADR-related morbidity and mortality. This assessment includes defining the most likely drug implicated in the allergic reaction, the probable mechanism(s), and the potential cross-reactive drugs that should be avoided
Search strategy and selection criteria
References (142)
- et al.
Severe cutaneous adverse reactions to drugs
Lancet
(2017) - et al.
Severe delayed cutaneous and systemic reactions to drugs: a global perspective on the science and art of current practice
J Allergy Clin Immunol Pract
(2017) - et al.
Evolving models of the immunopathogenesis of T cell-mediated drug allergy: the role of host, pathogens, and drug response
J Allergy Clin Immunol
(2015) - et al.
SJS/TEN 2017: building multidisciplinary networks to drive science and translation
J Allergy Clin Immunol Pract
(2018) - et al.
Perioperative anaphylaxis
Immunol Allergy Clin North Am
(2009) - et al.
Immune-mediated reactions to vancomycin: a systematic case review and analysis
Ann Allergy Asthma Immunol
(2016) - et al.
Severe delayed drug reactions: role of genetics and viral infections
Immunol Allergy Clin North Am
(2017) - et al.
The costs of adverse drug events in community hospitals
Jt Comm J Qual Patient Saf
(2012) - et al.
Adverse and hypersensitivity reactions to prescription nonsteroidal anti-inflammatory agents in a large health care system
J Allergy Clin Immunol Pract
(2017) - et al.
Frequency of self-reported drug allergy: a systematic review and meta-analysis with meta-regression
Ann Allergy Asthma Immunol
(2017)
Multiple drug intolerance syndrome: prevalence, clinical characteristics, and management
Ann Allergy Asthma Immunol
Stevens-Johnson syndrome and toxic epidermal necrolysis: assessment of medication risks with emphasis on recently marketed drugs. The EuroSCAR-study
J Invest Dermatol
Stevens-Johnson syndrome and toxic epidermal necrolysis: a cross-sectional analysis of patients in an integrated allergy repository of a large health care system
J Allergy Clin Immunol Pract
A comparative analysis between antibiotic- and nonantibiotic-associated delayed cutaneous adverse drug reactions
J Allergy Clin Immunol Pract
The high impact of penicillin allergy registration in hospitalized patients
J Allergy Clin Immunol Pract
Self-reported antibiotic allergy incidence and prevalence: age and sex effects
Am J Med
Prevention of allergic reactions to penicillin
J Allergy Clin Immunol
Risk factors for drug allergy
J Allergy Clin Immunol
Morbidity and mortality of Stevens-Johnson syndrome and toxic epidermal necrolysis in United States adults
J Invest Dermatol
Adverse reactions associated with oral and parenteral use of cephalosporins: a retrospective population-based analysis
J Allergy Clin Immunol
Dapsone is often tolerated in HIV-infected patients with history of sulfonamide antibiotic intolerance
J Allergy Clin Immunol Pract
Approach to the evaluation of adverse antibiotic reactions in patients with cystic fibrosis
Ann Allergy Asthma Immunol
Improving the effectiveness of penicillin allergy de-labeling
J Allergy Clin Immunol Pract
Amoxicillin allergy in children: five-day drug provocation test in the diagnosis of nonimmediate reactions
J Allergy Clin Immunol Pract
Safely diagnosing clinically significant penicillin allergy using only penicilloyl-poly-lysine, penicillin, and oral amoxicillin
J Allergy Clin Immunol Pract
Amoxicillin challenge without penicillin skin testing in evaluation of penicillin allergy in a cohort of Marine recruits
J Allergy Clin Immunol Pract
Parent-reported penicillin allergy symptoms in the pediatric emergency department
Acad Pediatr
Safety and outcomes of test doses for the evaluation of adverse drug reactions: a 5-year retrospective review
J Allergy Clin Immunol Pract
Adverse reactions during drug challenges: a single US institution's experience
Ann Allergy Asthma Immunol
Consequences of avoiding β-lactams in patients with β-lactam allergies
J Allergy Clin Immunol
Health care use and serious infection prevalence associated with penicillin “allergy” in hospitalized patients: a cohort study
J Allergy Clin Immunol
Are cephalosporins safe for use in penicillin allergy without prior allergy evaluation?
J Allergy Clin Immunol Pract
Addressing inpatient β-lactam allergies: a multihospital implementation
J Allergy Clin Immunol Pract
Pharmacogenomics of off-target adverse drug reactions
Br J Clin Pharmacol
Identification of a mast-cell-specific receptor crucial for pseudo-allergic drug reactions
Nature
Chapter 23: immunobiology of IgE and IgE receptors
Drug allergy: an updated practice parameter
Ann Allergy Asthma Immunol
Update on quinolone allergy
Curr Allergy Rep
Drug-induced cutaneous reactions. A report from the Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 to 1982
JAMA
Incidence of rash after amoxicillin treatment in children with infectious mononucleosis
Pediatrics
Clinicopathologic analysis of coxsackievirus a6 new variant induced widespread mucocutaneous bullous reactions mimicking severe cutaneous adverse reactions
J Infect Dis
Practical approach to determining costs and frequency of adverse drug events in a health care network
Am J Health Syst Pharm
Frequency of adverse drug reactions in hospitalized patients: a systematic review and meta-analysis
Pharmacoepidemiol Drug Saf
A value set for documenting adverse reactions in electronic health records
J Am Med Inform Assoc
Antibiotic-induced rash in patients with infectious mononucleosis
Ann Pharmacother
Do penicillins really increase the frequency of a rash when given during Epstein-Barr virus primary infection?
Clin Infect Dis
Drug allergies documented in electronic health records of a large healthcare system
Allergy
Self-reported drug allergy in a general adult Portuguese population
Clin Exp Allergy
Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics
N Engl J Med
International Consensus on drug allergy
Allergy
Cited by (331)
Are changes in antibiotic prophylaxis recommendations responsible for an increased risk of cefazolin allergy?
2024, Anaesthesia Critical Care and Pain MedicineDNA methylation profiling reveals potential biomarkers of β-lactams induced fatal anaphylactic shock
2024, Forensic Science InternationalInfectious Pulmonary Diseases
2024, Infectious Disease Clinics of North AmericaUtility of beta-lactam allergy assessment in patients receiving vancomycin for surgical prophylaxis
2024, Surgery in Practice and ScienceThe Management of Gonorrhea in the Era of Emerging Antimicrobial Resistance: What Primary Care Clinicians Should Know
2024, Medical Clinics of North AmericaThe distribution and determinants of physician-diagnosed drug allergy in a large, nationally representative sample of US children and adults
2024, Journal of Allergy and Clinical Immunology: In Practice